Mehmet Altan

18PUBLICATIONS
106CO-AUTHORS
Predictive and prognostic markersGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)Commercial lawMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

Hui Li, Lingzhi Hong, Pedro Rocha

|Sep 26, 2025
Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples.

Nejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez

|Aug 25, 2025
Predictors of outcomes in advanced non-small cell lung cancer treated with pembrolizumab maintenance.

Vamsidhar Velcheti, Xuezheng Sun, Maya Hanna

|Jul 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC.

Maliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong

|May 14, 2025
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil Model.

Hui Li, Morteza Salehjahromi, Myrna C B Godoy

|May 01, 2025
Safety and Tolerability of Lete-cel in NSCLC-Reply.

Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann

Pageof 3

Frequent Collaborators

7 joint publications

Jianjun Zhang

7 joint publications

John V Heymach

5 joint publications

J Jack Lee

4 joint publications

Xiuning Le